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Abstract—Staphylococcus aureus and coagulase-negative 
staphylococci (CoNS) are common causatives of superficial 
incisional surgical site infection (SSI). The source of the pathogens 
is still not fully diagnosed whether it is endogenous or exogenous 
particularly with regard to the extent of its resistance to antibiotics. 
Therefore, this study is designed to determine the rate of infection, 
the source of pathogens, and the extent of their resistance to 
antibiotics. For this purpose, pre-, intra- and post-operative 
swabs from the nasal and skin of patients undergoing surgeries 
and samples from the hospital environment have been collected 
and processed for isolation and identification of staphylococci. 
Bacterial analysis and antibiotic susceptibility profiles of the 
isolates are assessed by unweighted pair group method with 
arithmetic mean (UPGMA) analysis based on random amplified 
polymorphic DNA-polymerase chain reaction (RAPD-PCR) 
and disc diffusion test for antibiotics susceptibility profile. The 
microbiological and PCR results indicate that SSIs are found 
in 113/512 (22.07%), Staphylococcus spp. rated 67/512 (13.09%) of 
infections. Further analysis indicates that S. aureus, CoNS, and both 
of them were causes SSI with different rates 41/67 (61.2%), 23/67 
(34.3%), and 3/67 (4.5%), respectively. Results of RAPD-PCR for 
70 isolates reveal that 52/70 (74.28%) of SSIs are from endogenous 
source, followed by 10/70 (14.29%) and 8/70 (11.43%) from hospitals 
acquired and undetermined sources, respectively. Moreover, results 
of antibiotic susceptibility test reveal that 24/44 (54.5%) of isolates 
belong to methicillin-resistant Staphylococcus aureus; from both 
endogenous and exogenous sources with 13/24 (54.17%) and 11/24 
(45.83%), respectively.
Index Terms—Methicillin-resistant Staphylococcus aureus, 
Source of Infections, Staphylococcus spp., Surgical site infection.
I. Introduction
Surgical site infection (SSI) is a common postsurgical 
nosocomial infection that occurs at the operation site. It 
increases the occurrence of morbidity and mortality, leading 
to increased health-care costs through extended hospitalization 
times and the emergence of antimicrobial resistance in 
pathogens (Mangram et al., 1999). The Center for Disease 
Control and Prevention has classified SSIs as either incisional 
or organ/space infections. SSIs are further categorized into 
superficial (affecting skin and subcutaneous tissues, or deep 
(attacking deeper soft tissues) (Horan et al., 1992).
There are several risk factors related to SSI, including age, 
nutritional status, smoking, obesity, preexisting infection, 
diabetes and other chronic diseases, blood transfusion, 
prolonged hospitalization (either pre- or post-operative), 
poor surgical technique, prolonged duration of surgery, and 
inadequate sterilization of surgical instruments (Cheadle, 
2006; Owens and Stoessel, 2008). Aside from the inoculum 
of contaminant bacteria introduced into the incision either 
during or after the operation, the microenvironment and 
the immunological integrity of the host have importance in 
determining the severity of infection (Medeiros et al., 2005).
Bacteriological studies have shown that SSIs are usually 
caused by endogenous and/or exogenous bacteria that 
enter the operative wound either during or after surgery 
(Owens and Stoessel, 2008; Dancer et al., 2012; Berríos-
Torres et al., 2017). The most commonly isolated bacteria 
in SSIs are Staphylococcus aureus and coagulase-negative 
staphylococci (CoNS) (Anderson and Kaye, 2009; Pal et al., 
2019; Dohmen, 2006), which frequently colonize the skin 
and nares in the healthy population, and in pre-operative 
patients are associated with an elevated risk of SSI (Dohmen, 
2006). In general, patients who are nasal and skin carriers 
of staphylococci are 2–9 times more likely to develop an 
SSI, and it has been shown that 85% of SSIs can be traced 
to endogenous colonization of the patients (Skråmm et al., 
2014). Although the isolated bacteria from SSI depending on 
ARO-The Scientific Journal of Koya University 
Volume IX, No.1 (2021)  , Article ID:  ARO.10752,  08 pages 
DOI:10.14500/aro.10752 
Received: 16 November 2020; Accepted: 22 June 2021 
Regular research paper: Published: 30 June 2021 
Corresponding author’s e-mail: kameran.m.ali@spu.edu.iq 
Copyright © 2021 Kameran M. Ali, Bahrouz M. A. Al-Jaff. This 
is an open-access article distributed under the Creative Commons 
Attribution License.
 ARO p-ISSN: 2410-9355, e-ISSN: 2307-549X
http://dx.doi.org/10.14500/aro.10752 115
the surgical procedures, whereas the problem is that some 
of them are resistant to antibiotics, particularly methicillin-
resistant Staphylococcus aureus (MRSA), which increase the 
incidence of SSIs (Bhattacharya et al., 2016). The widespread 
use of broad-spectrum antibiotics leads to emergence of 
antimicrobial resistant strains in hospitals. The problem 
is more complicated in developing countries as a result of 
poor infection control practices, overcrowded hospitals, and 
inappropriate use of antimicrobials (Negi et al., 2015).
In spite of the comprehensive techniques and careful 
surgical procedures used to control infections, the rate of 
staphylococcal SSI remains a real threat in surgical settings 
(Mawalla et al., 2011). Therefore, it is important to identify 
whether the source of bacterial pathogens (Staphylococcus 
spp.) isolated from patients with post-operative SSI is the 
patients’ skin or contaminated items existent in the hospital 
environment (Reichman and Greenberg, 2009).
Determining the sources of SSI is a crucial avenue of 
research in remedying these problems and finding solutions 
to minimize the threat of SSI. However, there is to date no 
standardized diagnostic method for SSI infection and often no 
post-discharge surveillance system in place (WHO, 2016). The 
incidence rate of SSI has not yet been established in Kurdistan 
Region of Iraq. Therefore, this study aims to use various 
diagnostic methods to determine the rate and the source of 
bacterial SSIs, and to assess the risk of these causative agents 
through testing their antibiotic susceptibility profiles.
II. Materials and Methods
A. Sampling and Data Collection
A hospital-based cross-sectional study was conducted 
from August 2018 to July 2019 in three surgical centers of 
hospitals (Kalar General Hospital, Life Private Hospital and 
Sheray Naqib Hospital) in the Kalar city, Kurdistan, Iraq. 
A total of 512 patients (233 males, 279 females, and ages 
9–67 years) who had undergone surgeries were followed up 
for staphylococcal superficial incisional SSIs until they had 
fully recovered or were discharged from the hospital. Nasal 
and skin swabs were taken aseptically from patients on 
admission to the hospital and after operation completion from 
subcutaneous wounds. Swabs were also taken from elements 
within the hospital environment, including the instruments 
and disinfectants used for each patient. Clinical data were 
obtained from the patients’ files and by physical examination 
using structured and pretested questionnaires.
The patients who underwent surgery were continuously 
monitored for signs and symptoms of SSI during hospital 
admission and after discharge (follow-up on an outpatient 
basis) for 30 days of surveillance. Sterile cotton swabs were 
collected aseptically from superficial surgical wounds of each 
patient suspected of having SSI before the injury was cleaned 
with antiseptic. Swabs were obtained from the surgical sites 
while avoiding contamination by skin commensals and 
transported immediately to the molecular biology lab of 
Garmian University for processing by standard laboratory 
procedures (Elmer et al., 1997).
B. Isolation and Identification of Causative Agents
For isolation and preliminary identification, specimens 
were streaked on 5% sheep blood agar and mannitol salt 
agar, and then incubated for 24 h at 37°C. In case no 
bacterial growth, the plates were further incubated for 24 h 
more. Then, after 48 h the specimens with no growth, they 
were reported as negative. Identification at the species 
level depended on colony morphology, Gram’s staining, 
and conventional biochemical tests including catalase 
test, coagulase test, and detection of hemolysin activity 
(Forbes et al., 2007).
C. Molecular Identification by PCR
Identifications were confirmed by PCR using specific 
primers for each Staphylococcus species. The target genes 
have been selected for each species. Then, species-specific 
primers were designed using Primer-BLAST on NCBI. 
Finally, all primers were BLAST analyzed before they were 
synthesized by Macrogen Inc. (Seoul, Korea).
DNA extraction
Extraction of DNA from clinical isolates was performed 
according to the kit manufacturer’s instructions (Geneaid 
Biotech Ltd., New Taipei City, Taiwan). Concentration and 
purity (260/280 ratio) of the extracted DNA was checked by 
NanoDrop (Thermo Scientific, Waltham, MA, USA).
Multiplex PCR
S. aureus was detected using single PCR. However, 
CoNS detection was carried out in two sets of multiplex 
PCR as previously described by Kim et al., 2018. For this 
purpose, a pair of universal primers was added to each set 
of multiplex assays for the identification of CoNs species. 
16S rRNA sequencing was used for the identification 
of isolates that were not detected by the PCR sets that 
mentioned in Table I.
PCR amplification reactions were carried out with 
10 µl of MasterMix and 2.5 µl of template DNA for a final 
volume of 20 µl in a single pathogen tube, using a Gradient 
Thermocycler (Eppendorf, Germany). The protocol used 
included an initial denaturation at 95°C for 5 min, followed 
by 35 cycles of denaturation at 95°C for 30 s, primer 
annealing for 30 s, primer extension at 72°C for 45 s, and 
the final extension at 72°C for 5 min. The primer sequences, 
multiplex sets, concentrations, annealing temperature, and 
calculated lengths of the corresponding amplicons are listed 
in Table I.
D. Determination the Source of Causative Staphylococci 
Using Random Amplified Polymorphic DNA-polymerase 
Chain Reaction (RAPD-PCR) and UPGMA Analysis
Randomly amplified polymorphic DNA analysis by PCR 
(RAPD-PCR) was performed for genotyping of S. aureus and 
CoNS, and to ascertain the source of infection by comparing 
them with each other. The RAPD-PCR reaction was performed 
using 10-mer primers 5’-AGCGTCACTG-3’ (Casey et al., 
2006), 5’-GCGATCCCCA-3’, 5’-AGCGTCACTG-3’, and 
5’-TGACCCGCC-3’ (Pereira et al., 2002). The reaction 
was carried out in a 20 µl reaction volume containing 10 µl 
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TABLE I
List of primers used in this study
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MasterMix, 1.2 µl primers, 2.5 µl DNA template, and 6.3 
µl sterile deionized water. The negative control for each 
primer contained all the components except template DNA. 
The amplification procedure was comprised of one cycle 
for 5 min at 94°C, followed by 5 low-stringency cycles of 
30 sec at 94°C, 2 min at 20°C, and 2 min at 72°C, and 30 
high-stringency cycles of 30 sec at 94°C, 1 min at 32°C, 
and 2 min at 72°C. The amplification was concluded within 
5 min at 72°C. Then, 10 µl of each product and 5 µl of a 
100 bp DNA molecular mass ladder (TransGen Biotech Co., 
Ltd., Beijing, China) were loaded into separate wells in a 2% 
agarose gel containing 5 µl of safe dye and electrophoresed 
at 100 V for 1 h in 1% TBE buffer. The clearest and most 
reproducible bands were chosen for the determination of their 
presence or absence in each strain. Faint bands that could not 
be systematically visualized were not taken into account.
Typing of bacteria was used for monitoring pathogens 
and revealing the source of infection. The RAPD patterns 
were considered to be different when the profiles differed 
by at least one band (Burnie et al., 1997; Marsou et al., 
2001). Here, we used RAPD-PCR followed by agarose 
gel electrophoresis for typing of isolates that were 
collected from pre-, during, and post-operative nasal, 
skin, and subcutaneous wound specimens of patients 
with SSI, as well as the hospital environment. The 
relationships among S. aureus and CoNS RAPD profiles 
were determined by unweighted pair group method with 
arithmetic mean (UPGMA) dendrogram cluster analysis 
(Addinsoft, 2020).
E. Antibacterial Susceptibility Testing by Disc Diffusion 
Method (Kirby–Bauer Test)
Antibacterial susceptibility testing of Staphylococci spp. 
was performed using the disc diffusion method on Müeller-
Hinton agar medium (Oxoid, UK). The antibiotic discs with 
respective concentrations prescribed in the study area included 
the known six antibiotic classes (Oxoid, UK) and were selected 
as they used in testing resistance for nosocomial bacteria 
in addition to that mentioned in inpatients prescriptions in 
local hospitals and Clinical Laboratory Institute Standards 
(CLSI) guidelines (Wayne, 2017). The used antibiotics 
were penicillin G (10 IU), ampicillin (10 µg), amoxicillin/
clavulanic acid (20/10 µg), cephalothin (30 µg), clindamycin 
(15 µg), azithromycin (15µg), tetracycline (30 µg), rifampicin 
(5 µg), erythromycin (15 µg), vancomycin (30 µg), 
ceftriaxone (30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), 
gentamycin (10 µg), trimethoprim/sulfamethoxazole (25 µg), 
amikacin (30 µg), nitrofurantoin (100 µg), imipenem (10 µg), 
and meropenem (10 µg). MRSA was identified using cefoxitin 
(30 µg) and oxacillin (1 µg) and interpreted according to 
CLSI guidelines (2017).
One to three colonies were picked up from a new pure 
culture and mixed aseptically in a test tube containing 3 ml 
sterile saline to form a homogenous suspension. Turbidity 
of the suspension was adjusted to a 0.5 McFarland standard 
using a photometric device (Densimat, BioMérieux). Within 
15 min, a sterile cotton swab was dipped into the bacterial 
suspension, excess fluid was removed, and the swab used 
to evenly streak the surface of Müeller-Hinton agar in three 
different planes, rotating the plates approximately 60° each 
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time. The rim of the plate was then swabbed once. After 
5 min, the selected antibiotic discs were placed aseptically on 
the surface of the inoculated media using sterile forceps. The 
plates were inverted and incubated aerobically at 35–37°C 
for 18–24 h, after which the mean radii diameters of the 
inhibition zone were measured in millimeters using calipers 
and interpreted using CLSI guidelines (Wayne, 2017). The 
standard reference strain S. aureus ATCC 25923 was used 
to assess the disc’s quality. Multidrug resistance (MDR) was 
considered as resistance to at least one antibiotic in three or 
more antibacterial categories (Magiorakos et al., 2012).
F. Ethics Statement
The study was approved by the Ethical Committee of the 
Department of Medical Lab. Technology, Kalar Technical 
Institute, Sulaimani Polytechnic University, the Declaration 
of Helsinki regarding the ethical principles for medical 
research involving human subjects was considered. Patients’ 
consent was acquired; for minors, guardians’ consent was 
acquired.
G. Statistical Analysis
Statistical analysis was performed using the Statistical 
Package for the Social Sciences version 16.0 software 
program (IBM Corporation, Armonk, NY, USA) to determine 
associations of SSI incidence in patients. P < 0.05 was 
considered as statistically significant. The incidence rate 
was expressed as the percentage of patients who acquired 
SSI among those admitted to surgical centers. Antibiotic 
resistance was expressed as the ratio between the numbers 
of isolates confirmed as resistant over the total number of 
isolates subjected to the antibiotic.
III. Results
A. Rate and Etiology
Obtained results of molecular identification were 
exhibited that the SSI rate of those included in the study 
was 113/512 (22.07%). The rate of staphylococcal SSI 
was 67/512 (13.09%); infection by S. aureus occurred in 
41/67 patients (61.2%), infection by CoNS occurred in 
23/67 (34.3%), and infection by both S. aureus and CoNS 
occurred in 3/67 (4.5%), Table II. Most staphylococcal 
infections (95.5%) were caused by a single species, with the 
remaining 4.5% caused by multiple species. Staphylococcus 
spp. were isolated from 29/67 male patients (43.3%) and 
38/67 from female patients (56.7%).
Among the 70 isolated staphylococci, 26 of them 
were CoNS species and they distributed as 17 (65.38%) 
S. epidermidis, 4 (15.38%) S. haemolyticus, 3 (11.54%) 
S. capitis, and 1 (3.85%) of each S. warneri and S. hominis.
B. Determination the Source of Causative Agents Using 
RAPD-PCR and UPGMA Analysis
RAPD typing for both 44 S. aureus and 26 CoNS SSI 
isolates produced amplicons with a range of profiles. UPGMA 
analysis for S. aureus revealed three clusters, with 10 SSI 
isolates showing similarities in banding patterns to those of 
exogenous surgical ward isolates; the other isolates were 
determined to show non-similar patterns. The typing profile 
revealed that 29 infections were caused by endogenous 
S. aureus not related to surgical centers, Fig. 1. UPGMA 
analysis revealed that out of 26 CoNS isolates, 23 of them 
were similar to nasal and skin isolates of the same patients, 
revealing the endogenous source of the causative pathogens, 
all S. haemolyticus, S. warneri, and S. hominis isolates were 
sourced from the endogenous source, whereas two isolates of 
S. epidermidis and single isolate of S. capitis were appeared 
to be from the exogenous source, Fig. 2.
Regarding the source of Staphylococcus spp. causing 
SSI, UPGMA analysis revealed that 52/70 (74.28%) were 
sourced from patients themselves (endogenous source), 
whereas 10 (14.29%) were sourced from the hospital 
environment (exogenous source) and 8 (11.43%) were from 
an undetermined exogenous source, Fig. 3a.
C. Antibiotic Resistance Profile
All staphylococci isolated from SSIs were resistant to at 
least one class of the antibiotics used; 68.6% of them were 
multiple drug resistant (MDR). Most of S. aureus and CoNS 
were resistant to penicillin G (95.5% and 88.5%, respectively), 
with moderate resistance to gentamicin, tetracycline, 
erythromycin, and trimethoprim/sulfamethoxazole. S. aureus 
showed higher resistance than CoNS to those drugs that 
mentioned above. MRSA was recorded in 54.5% of the 
isolated staphylococci; the majority of MRSA sources (13/24, 
54.17%) were the patients themselves, whereas the remainder 
(11/24, 45.83%) were exogenous or undetermined. About 
20.5% of isolated MRSA were resistant to vancomycin. Out 
of 26 CoNS isolates, 5 (19.2%) were resistant to methicillin: 
S. epidermidis (3), S. haemolyticus (1), and S. capitis 
(1). The resistance to the other antibiotics was variable. 
S. aureus and CoNS were highly susceptible to rifampicin, 
showing resistances to only 13.6% and 11.5%, respectively. 
The susceptibility to nitrofurantoin was also high (8.2% and 
15.4% resistance, respectively), Table III.
Out of 44 S. aureus SSI isolates, 10 had an antibiotic 
resistance profile with a high degree of similarity to that of 
a surgery environment isolate. Of the other 34 isolates, 29 of 
them showed profiles identical to those of the same patients’ 
pre-surgical isolates, whereas the remaining 5 showed no 
similarity in profile to pre-surgical or environmental isolates. 
The antibiotic profile of 26 CoNS isolates revealed that 22 
of them were identical to the same patients’ pre-surgical 
isolates, whereas the other 4 showed no similarity in profile 
to pre-surgical and environmental isolates.
TABLE II
Staphylococcus spp. isolated in the surgical site infections
Bacterial species Number of SSI (%) Total bacterial no. (%)
SSI patients with S. aureus 41 (61.19%) 44 (62.86%)
SSI patients with CoNS 23 (34.33) 26 (37.14%)
SSI patients with both S. aureus 
and CoNS
3 (4.48%)
Total 67 (100%) 70 (100%)
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Fig. 2. UPGMA dendrogram analysis of RAPD profiles from CoNS isolates. SE: Staphylococcus epidermidis, SH: Staphylococcus haemolyticus,  
SC: Staphylococcus capitis, SHo: Staphylococcus hominis, SW: Staphylococcus warneri.




































A. UPGMA Analysis B. Antibiotic Profile
S. aureus CoNS
Fig. 3. The percentage of Staphylococcal Surgical Site Infections Source: (a) The source of staphylococcal SSI according UPGMA analysis; (b) the 
source of staphylococcal SSI according to antibiotic profile.
 ARO p-ISSN: 2410-9355, e-ISSN: 2307-549X
http://dx.doi.org/10.14500/aro.10752 119
Results of antibiotic resistance profiling show that 
51/70 (72.86%) of Staphylococcus caused SSIs were of 
an endogenous source, 10 (14.29%) were sourced from 
the hospital environment, and 9 (12.86%) were of an 
undetermined source, Fig. 3b.
IV. Discussion
Despite advances in surgical technique and improved 
understanding of the pathogenesis of wound infections, 
management of SSIs represents a significant challenge to any 
surgical health-care facility procedure (Medeiros et al., 2005, 
Sattar et al., 2019). Globally, SSI rates have ranged from 2.5% 
to 41.9% (Mawalla et al., 2011). The rate reported in this 
study (22.07%) is similar to those reported in related studies 
of some developing countries (Giri et al., 2013; Mezemir 
et al., 2020), but higher than those recorded for developed 
countries (Fan et al., 2014; Roumbelaki et al., 2008). In fact, 
the literature has mentioned that incidence rates of SSIs in 
developing countries may be up to 3–4 times higher than those 
of developed countries (Danzmann et al., 2013; Curcio et al., 
2019; Mezemir et al., 2020), the difference may be due to 
reasons linked to patient-related and procedure-related factors 
including poor hospital infrastructure, poor hygiene, failure 
to follow-up on the patient’s treatment, overwhelmed health-
care services due to population burden, and contamination 
from the external environment (Mukagendaneza et al., 2019; 
Assawapalanggool et al., 2016).
The rate of staphylococcal SSI reported in this study is in 
agreement with a study that revealed the predominance of 
Staphylococci spp. (Rolston et al., 2014) in SSIs; however, 
other studies including studies conducted in Baghdad 
and Duhok cities have reported a lower proportion of 
Staphylococci spp. (Mohammed et al., 2020; Merdaw, 2011; 
Dessie et al., 2016). In this study, S. aureus was found to 
be the causative agent of more than one-third of infections 
and it has been found to be the single greatest cause of 
SSIs in the current study, as well as in the previous studies 
worldwide (Bhattacharya et al., 2016; Negi et al., 2015). 
Indeed, S. aureus is a widespread member of skin and 
nasal microbiota, with high proximity to potential surgical 
points of entry. During surgery, the integrity of the skin 
may be breached, leading to skin and soft-tissue infection 
by Staphylococcus spp. already inhabited on the skin of 
patients or found in the environment, on surgical instruments, 
or on the hands of health care workers (David and Daum, 
2010; Reichman and Greenberg, 2009). The difference in 
the distribution of SSI bacteria may be due to variations 
in common pathogens inhabiting surgery centers, aseptic 
techniques, infection control and prevention policies, 
geographical distribution, resistance patterns of the bacterial 
isolates, surgical procedures performed, contamination due to 
poor personal hygiene or post-procedural contamination, and 
outbreaks (Mukagendaneza et al., 2019; Rao et al., 2013).
Most staphylococcal isolates from this study were found 
to be multidrug resistant. They were generally susceptible to 
carbapenems, rifampicin, and nitrofurantoin, but resistant to 
penicillinase-sensitive penicillins, tetracycline, gentamicin, 
and trimethoprim/sulfamethoxazole. In consistent to this 
finding, similar results were reported by Dessie et al., 2016. 
The high rate of resistance to these drugs may be attributed 
to the fact that these antibiotics are widely prescribed by 
physicians for both inpatients and outpatients to treat various 
bacterial infections, in addition to their relatively cheap price 
(Rao et al., 2013). The prophylactic use of antibiotics before 
and/or after surgery may induce new resistance bacteria 
through the transmission of resistance genes from other 
established bacterial species in the hospital environment 
and it became difficult to control (Schentag et al., 1998). 
The development and spread of resistant bacterial strains 
have emerged as a global problem. The appearance of MDR 
bacterial strains over the past decades has been regarded as 
an inevitable genetic response to the strong selective pressure 
imposed by antimicrobial chemotherapy (Negi et al., 2015).
More than half of S. aureus isolates were MRSA that were 
resistant to the penicillinase-resistant penicillins, oxacillin, and 
cefoxitin, which are similar to results reported by the previous 
studies on SSI isolated S. aureus (Bhattacharya et al., 2016; 
Khairy et al., 2011). However, it appears that this proportion 
cannot be generalized for SSI infections globally. For 
example, a study has revealed that 15.7% MRSA among SSI 
isolates in India (Negi et al., 2015). Surgical patients with 
MRSA carriage can increase the risk of SSI development; 
the previous study by Safdar and Bradley (2008) illustrated 
that patients colonized with MRSA were 4 times more likely 
to develop an infection than patients colonized with MSSA. 
It has been mentioned that the variation in the prevalence 
of MRSA may depend on pre- and post-operative antibiotic 
TABLE III








n % n %
1 Penicillin G (10 IU) 42 95.5 23 88.5
2 Ampicillin (10 μg) 39 88.6 18 69.2
3 Amoxicillin/clavulanate (30 μg) 26 59.1 14 53.8
4 Cephalothin (30 μg) 19 43.2 11 42.3
5 Imipenem (10 μg) 21 47.7 5 19.2
6 Meropenem (10 μg) 19 43.2 3 11.5
7 Oxacillin (1 μg) 24 54.5 5 19.2
8 Cefoxitin (30 μg) 23 52.3 5 19.2
9 Cefepime (30 μg) 15 34.1 6 23.1
10 Levofloxacin (5 μg) 15 34.1 2 7.7
11 Ciprofloxacin (5 μg) 25 56.8 15 57.7
12 Erythromycin (15 μg) 29 65.9 15 57.7
13 Clindamycin (10 μg) 26 59.1 14 53.8
14 Azithromycin (15 μg) 15 34.1 12 46.2
15 Tetracycline (30 μg) 31 70.5 17 65.4
16 Rifampicin (5 μg) 6 13.6 3 11.5
17 Vancomycin (30 μg) 9 20.5 2 7.7
18 Gentamicin (10 μg) 38 86.4 15 57.7
19 Amikacin (30 μg) 32 72.7 14 53.8
20 Nitrofurantoin (100 μg) 8 18.2 4 15.4
21 Trimethoprim/ 
sulfamethoxazole (25 μg)
28 63.6 19 73.1
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use, as well as patient surveillance programs (Bhattacharya 
et al., 2016). However, results of the current study were 
revealed that the highest proportion (88.57%) belongs to pre-
operational patients’ skin, nasal, and hospital environment. 
This was confirmed through isolation of same bacterial 
types from post-operative SSIs which indicates that the most 
significant source of MRSA is from the patients themselves.
The RAPD-PCR and UPGMA analyses revealed that 
the incidence rate of endogenous-sourced SSIs (including 
S. aureus, MRSA, and CoNS) was 3 times higher than that 
of exogenous sourced SSIs. Most SSIs were reported to be 
caused by patients’ body microbiota, whereas infections 
caused by exogenous bacteria following surgery were less 
common (Skråmm et al., 2014; Leaper et al., 2008; Perl et al., 
2002). S. aureus colonizes the skin and nose of human beings, 
and several studies have identified patients’ nasal and skin S. 
aureus as a major risk factor for SSIs (Munoz et al., 2008; 
Liu et al., 2017; Wertheim et al., 2005). MRSA can spread 
from the anterior nares to other areas on the skin surface 
and then contaminate the surgical site (Leaper et al., 2008; 
Women’s and Health, 2011). It has been reported that most 
of S. aureus strains are causing SSIs and they have the same 
identity as isolates from the nares of the patients themselves, 
these results were confirmed by Perl et al., 2002. In this 
study, the identification of the causative identities for both 
S. aureus and CoNS, including MRSA, and their endogenous 
or exogenous sources, was performed through RAPD-PCR 
genotyping, and involved actual matching of isolates with 
pre-, inter-, and post-operative isolates.
V. Conclusion
Isolation of S. aureus and CoNS with MDR was strongly 
associated with post-operative SSIs. The incidence rate 
of staphylococcal SSIs is high, and these SSIs including 
infections caused by MRSA were sourced mostly from the 
skin and nares of the patients themselves, rather than the 
surgery ward or hospital environment.
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